home / lobbying / lobbying_activities

lobbying_activities: 1546583

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1546583 0354785d-fe5d-46b7-8a16-220ad90c3912 Q2 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2014 second_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Issues regarding prescription drug coverage for DoD Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-07-07T16:20:17.773000-04:00
Powered by Datasette · Queries took 0.318ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API